Skip to main content
OpenTrials

Clinical trial condition

Endometrial Adenocarcinoma

Explore clinical trials studying Endometrial Adenocarcinoma. Study availability and eligibility vary by location and protocol.

47 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Adenocarcinoma trial results

Completed

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

NCT03460483

Conditions
Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +28 more
Locations
  • Summa Akron City Hospital/Cooper Cancer Center Akron, Ohio, United States
  • Aultman Health Foundation Canton, Ohio, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • TriHealth Cancer Institute-Westside Cincinnati, Ohio, United States
View Trial Details
Completed

Pembro/Carbo/Taxol in Endometrial Cancer

NCT02549209

Conditions
Endometrial Adenocarcinoma, Endometrial Cancer, Endometrial Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers Mesa, Arizona, United States
  • Northwestern University, Robert H. Lurie Cancer Center Chicago, Illinois, United States
  • Northwestern Medicine Lake Forest Hospital Lake Forest, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View Trial Details
Completed

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

NCT01307631

Conditions
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +2 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Charlestown, Massachusetts, United States
View Trial Details
Completed

Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

NCT01968317

Conditions
Endometrial Adenocarcinoma, Endometrial Atypical Hyperplasia, Endometrial Hyperplasia, +6 more
Locations
  • Obstetrics and Gynecology Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Changning Maternity & Infant Health Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Sixth People's Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT01935973

Conditions
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, +3 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 22 locations
View Trial Details

Related conditions